Monday, Sep 28, 2020 | Last Update : 06:00 PM IST

188th Day Of Lockdown

Maharashtra1339232103001535571 Andhra Pradesh6756746050905708 Tamil Nadu5808085251549313 Karnataka5755664622418582 Uttar Pradesh3870853258885594 Delhi2711142366515235 West Bengal2474252169214781 Odisha209374173571850 Telangana1872111564311107 Bihar178882164537888 Kerala175385117917678 Assam169985139977655 Gujarat1332191132403417 Rajasthan1288591077181441 Haryana1237821059901307 Madhya Pradesh117588932382207 Punjab107096840253134 Chhatisgarh9856566860777 Jharkhand7770964515661 Jammu and Kashmir69832495571105 Uttarakhand4533233642555 Goa3107125071386 Puducherry2548919781494 Tripura2412717464262 Himachal Pradesh136799526152 Chandigarh112128677145 Manipur9791760263 Arunachal Pradesh8649623014 Nagaland5768469311 Meghalaya5158334343 Sikkim2707199431 Mizoram178612880

GlaxoSmithKline

US strikes a $2 billion deal for 100 million doses of coronavirus vaccine

The agreement calls for US to pay Sanofi and GlaxoSmithKline up to $2.1 billion to supply it with enough vaccines for 50 million people

01 Aug 2020 9:51 AM

Nestle, Unilever in pole position for GSK's Indian Horlicks business: reports

GSK is in exclusive talks with Unilever to strengthen its position in India, its most important emerging market.

28 Nov 2018 1:50 PM

First ever HIV immunotherapy drug proves safe in phase 1 trial, paves way to cure

Phase 1 trial is milestone for team at University of North Carolina, which won $20 million grant to make their ideas a reality.

22 Sep 2018 10:28 AM

GSK's two-drug HIV regimen wins European panel approval

The new HIV treatment, Juluca, is a fixed-dose once-daily tablet that combines two previously approved drugs, dolutegravir and rilpivirine.

24 Mar 2018 10:24 AM

CDC discovers new meningitis vaccine manufactured by GlaxoSmithKline could prevent 91% of strains

This life-threatening illness can infect the bloodstream and the lining that surrounds the brain and spinal cord.

23 Nov 2017 3:31 PM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT